Sabby Management’s MEDGENICS INC WT PUR COM EXP 03/31/16 MDGN.WS Stock Holding History

Sabby Management’s Portfolio MDGN.WS Stock Details MDGN.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,564,370	Closed	-$1.17M	–	379
2016 Q1	$1.17M	Buy	1,564,370 +34,844	+2%	+$10.6K	0.06%	145
2015 Q4	$1.38M	Buy	1,529,526 +75,886	+5%	+$139K	0.08%	156
2015 Q3	$2.54M	Buy	1,453,640 +13,800	+1%	+$36.9K	0.1%	131
2015 Q2	$1.44M	Buy	+1,439,840	New	+$3.82M	0.05%	198
2015 Q1	–	Sell	-1,271,240	Closed	-$922	–	346
2014 Q4	$922	Buy	1,271,240 +429,528	+51%	+$623K	0.03%	162
2014 Q3	$673	Buy	841,712 +11,400	+1%	+$19.2K	0.03%	170
2014 Q2	$1.11M	Buy	830,312 +13,262	+2%	+$35.4K	0.05%	144
2014 Q1	$940K	Buy	+817,050	New	+$2.68M	0.05%	137

Sabby Management's MDGN.WS Position: Q2 2016 in Review

Sabby Management sold out of MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) in Q2 2016, closing a stake of 1,564,370 shares — an estimated $1.17M sold.

Sabby Management first reported a position in MDGN.WS in Q1 2014 and held it in 8 quarters. The position peaked at $2.54M in Q3 2015. 0 funds tracked by Wall St. Rank hold MDGN.WS as of Q2 2016.

Sabby Management reported no remaining MEDGENICS INC WT PUR COM EXP 03/31/16 position as of Q2 2016 after selling out during the quarter.
Sabby Management sold 1,564,370 MEDGENICS INC WT PUR COM EXP 03/31/16 shares in Q2 2016, an estimated $1.17M.
Sabby Management first reported a position in MEDGENICS INC WT PUR COM EXP 03/31/16 in Q1 2014 and held it in 8 quarters.
Sabby Management's MEDGENICS INC WT PUR COM EXP 03/31/16 position peaked at $2.54M in Q3 2015.
0 funds tracked by Wall St. Rank held MEDGENICS INC WT PUR COM EXP 03/31/16 as of Q2 2016.

Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.